Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Riesen

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1981
Studies on retinal microangiopathy and coronary macroangiopathy in rats with streptozotocin-induced diabetesS Waber, V Meister, G L Rossi, et al.
Diabetologia|May 1, 1993
Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor IP D Zenobi, P Holzmann, Y Glatz, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1991
High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean)P Bovet, C Shamlaye, A Kitua, et al.
Cancer Chemotherapy and Pharmacology|August 5, 2010
Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonatesM Joerger, A Templeton, D Köberle, et al.
Progress in Clinical and Biological Research|January 1, 1988
Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresisW F Riesen, E Sturzenegger, C Imhof, et al.
Schweizerische Medizinische Wochenschrift|January 4, 1986
[Management of hypercholesteremia by extracorporeal immune adsorption]W F Riesen, C Imhof, E Sturzenegger, et al.
Diabetes Care|October 1, 1991
Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patientsC Ferrier, P Ferrari, P Weidmann, et al.
Atherosclerosis|February 1, 1990
Effects of long-term, self-monitored exercise on the serum lipoprotein and apolipoprotein profile in middle-aged menB Marti, E Suter, W F Riesen, et al.
Drugs|January 1, 1992
Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patientsC Ferrier, P Ferrari, P Weidmann, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type IIH Saxenhofer, P Weidmann, W F Riesen, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1981
Studies on retinal microangiopathy and coronary macroangiopathy in rats with streptozotocin-induced diabetesS Waber, V Meister, G L Rossi, et al.
Diabetologia|May 1, 1993
Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor IP D Zenobi, P Holzmann, Y Glatz, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1991
High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean)P Bovet, C Shamlaye, A Kitua, et al.
Cancer Chemotherapy and Pharmacology|August 5, 2010
Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonatesM Joerger, A Templeton, D Köberle, et al.
Progress in Clinical and Biological Research|January 1, 1988
Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresisW F Riesen, E Sturzenegger, C Imhof, et al.
Schweizerische Medizinische Wochenschrift|January 4, 1986
[Management of hypercholesteremia by extracorporeal immune adsorption]W F Riesen, C Imhof, E Sturzenegger, et al.
Diabetes Care|October 1, 1991
Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patientsC Ferrier, P Ferrari, P Weidmann, et al.
Atherosclerosis|February 1, 1990
Effects of long-term, self-monitored exercise on the serum lipoprotein and apolipoprotein profile in middle-aged menB Marti, E Suter, W F Riesen, et al.
Drugs|January 1, 1992
Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patientsC Ferrier, P Ferrari, P Weidmann, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type IIH Saxenhofer, P Weidmann, W F Riesen, et al.
Pageof 8